123
Participants
Start Date
January 31, 2022
Primary Completion Date
February 13, 2023
Study Completion Date
February 13, 2023
KX- 826 dosed at 2.5mg
2.5mg of the investigational drug to be applied topically to scalp twice daily for 24 weeks
KX-826 dosed at 5mg
5mg of the investigational drug to be applied topically to scalp once daily for 24 weeks
KX-826 dosed at 5mg
5mg of the investigational drug to be applied topically to scalp twice daily for 24 weeks
Matching placebo to KX-826
Placebo applied topically to scalp twice daily or once daily for 24 weeks
Qway Research LLC, Hialeah
Evoution Clinical Trials, Hialeah Gardens
Innovation Medical Group, LLC, Palmetto Bay
Anchor Medical Research, LLC, Miami
Palm Beach Research Center, West Palm Beach
DelRicht Research, Baton Rouge
Clinical Trials of Texas, LLC, San Antonio
First OC Dermatology, Fountain Valley
ALLCUTIS Research, LLC, Beverly
ALLCUTIS Research, LLC, Portsmouth
Suzhou Kintor Pharmaceutical Inc,
INDUSTRY